Using acupuncture, dry needling, and Botox to treat myofascial pain syndrome
Comparative Efficacy of Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome Using Electromyography and Visual Analogue Scale: A Randomized Clinical Trial
This study is testing whether acupuncture, dry needling, or Botox can help people aged 15 to 60 with myofascial pain feel better.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 39 (estimated) |
| Ages | 15 Years to 60 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06013644 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of acupuncture, dry needling, and Botox injections in managing myofascial pain dysfunction syndrome. Patients aged 15 to 60 with symptoms such as muscle spasms and trigger points in the masticatory muscles will be recruited from the outpatient clinic of the Oral and Maxillofacial Surgery department at Cairo University. Participants will be divided into three groups, each receiving one of the treatment techniques over a period of 4-6 weeks, with assessments conducted at 2 and 6 months post-intervention using electromyography and visual analogue scales.
Who should consider this trial
Good fit: Ideal candidates are adults aged 15 to 60 with myofascial pain dysfunction syndrome and identifiable trigger points in their masticatory muscles.
Not a fit: Patients with severe bleeding tendencies, psychological disturbances, or major systemic disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new effective treatment option for patients suffering from myofascial pain dysfunction syndrome.
How similar studies have performed: Previous studies have shown promising results with acupuncture and dry needling for myofascial pain, but the combination with Botox is less commonly tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Accepts Healthy Volunteers Inclusion Criteria: * Healthy Volunteers * MPDS patient * Adult patients of both sexes, aged from 15 to 60 years * signs and symptoms of pain or muscles spams * Trigger points in masticatory muscles * Patients had not received any other form of surgical treatment related to TMJ disorders * Cooperative patient Exclusion Criteria: * Severe bleeding tendency, e.g. anticoagulant therapy, thrombocytopenia * Edentulous patients, and total dental prosthesis. * Psychologically disturbed and mental disturbance patients * major systemic disorders (- Valvular heart disease: avoid indwelling needles) * seizure patients * A confirmed or suspected diagnosis of an inflammatory disorder and autoimmune. * Patient on Medication (insulin- corticosteroids, nonsteroidal anti-inflammatory therapy or narcotics, muscle relaxants, herbal medicines.) * Analgesic or anti-depressants over the last 2 weeks. * Any anatomical abnormality in TMJ. * Pregnant women. * Allergies to metals.
Where this trial is running
Cairo
- Wajma Sayed Karim Al Sayed — Cairo, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.